Saratoga Health & Biotechnology A (SHPAX)
| Fund Assets | 10.10M |
| Expense Ratio | 2.72% |
| Min. Investment | $250 |
| Turnover | 17.00% |
| Dividend (ttm) | 0.25 |
| Dividend Yield | 1.20% |
| Dividend Growth | -75.16% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 10, 2024 |
| Previous Close | 21.41 |
| YTD Return | 12.72% |
| 1-Year Return | 4.69% |
| 5-Year Return | 40.64% |
| 52-Week Low | 17.98 |
| 52-Week High | 21.32 |
| Beta (5Y) | n/a |
| Holdings | 29 |
| Inception Date | Jul 15, 1999 |
About SHPAX
Saratoga Health & Biotechnology Portfolio Fund Class A is a mutual fund that primarily targets the health care and biotechnology sectors. The fund seeks long-term capital growth by investing at least 80% of its assets in equity securities of companies engaged in health care, pharmaceuticals, medical products, research, and biotechnology, both in the United States and internationally. Managed since 1999, it holds a diversified portfolio with approximately 32 holdings and notable concentrations in large-cap health care companies. Its top holdings include prominent industry names such as McKesson, Amgen, and Intuitive Surgical, reflecting a focus on market leaders within health innovation. The fund has an annual expense ratio of around 2.7% and requires a minimum initial investment of $250. With a strategy centered on growth in sectors driven by advances in medicine and technology, Saratoga Health & Biotechnology Portfolio Fund Class A plays a specialized role for investors seeking specific exposure to the evolving health and biotechnology industries.
Performance
SHPAX had a total return of 4.69% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.24%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
48.91% of assets| Name | Symbol | Weight |
|---|---|---|
| Amgen Inc. | AMGN | 5.82% |
| Cencora, Inc. | COR | 5.66% |
| McKesson Corporation | MCK | 5.62% |
| Cardinal Health, Inc. | CAH | 5.18% |
| Novartis AG ADR | NVSN.MX | 4.80% |
| Exelixis, Inc. | EXEL | 4.70% |
| Dreyfus Institutional Reserves Funds - Dreyfus Institutional Preferred Government Money Market Fund | DSVXX | 4.42% |
| United Therapeutics Corporation | UTHR | 4.33% |
| Jazz Pharmaceuticals plc | JAZZ | 4.20% |
| The Cigna Group | CI | 4.19% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 10, 2024 | $0.2534 | Dec 11, 2024 |
| Dec 8, 2023 | $1.0202 | Dec 11, 2023 |
| Dec 9, 2022 | $1.2749 | Dec 12, 2022 |
| Dec 10, 2021 | $0.7883 | Dec 13, 2021 |
| Dec 11, 2020 | $2.5794 | Dec 11, 2020 |
| Dec 11, 2019 | $0.9077 | Dec 11, 2019 |